|
1
|
Li J, LaMarca B and Reckelhoff JF: A model
of preeclampsia in rats: The reduced uterine perfusion pressure
(RUPP) model. Am J Physiol Heart Circ Physiol. 303:H1–H8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dragun D and Haase-Fielitz A: Low
catechol-O-methyltransferase and 2-methoxyestradiol in
preeclampsia: More than a unifying hypothesis. Nephrol Dial
Transplant. 24:31–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fushima T, Sekimoto A, Minato T, Ito T, Oe
Y, Kisu K, Sato E, Funamoto K, Hayase T, Kimura Y, et al: Reduced
uterine perfusion pressure (RUPP) model of preeclampsia in mice.
PLoS One. 11:e01554262016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Talebianpoor MS and Mirkhani H: The effect
of tempol administration on the aortic contractile responses in rat
preeclampsia model. ISRN Pharmacol. 2012:1872082012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
AbdAlla S, Lother H, el Massiery A and
Quitterer U: Increased AT(1) receptor heterodimers in preeclampsia
mediate enhanced angiotensin II responsiveness. Nat Med.
7:1003–1009. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McKinney D, Boyd H, Langager A, Oswald M,
Pfister A and Warshak CR: The impact of fetal growth restriction on
latency in the setting of expectant management of preeclampsia. Am
J Obstet Gynecol. 214:395.e1–e7. 2016. View Article : Google Scholar
|
|
7
|
Sato K, Iemitsu M, Matsutani K, Kurihara
T, Hamaoka T and Fujita S: Resistance training restores muscle sex
steroid hormone steroidogenesis in older men. FASEB J.
28:1891–1897. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shin YY, Jeong JS, Park MN, Lee JE, An SM,
Cho WS, Kim SC, An BS and Lee KS: Regulation of steroid hormones in
the placenta and serum of women with preeclampsia. Mol Med Rep.
17:2681–2688. 2018.PubMed/NCBI
|
|
9
|
Pennington KA, Schlitt JM, Jackson DL,
Schulz LC and Schust DJ: Preeclampsia: Multiple approaches for a
multifactorial disease. Dis Model Mech. 5:9–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hertig A, Liere P, Chabbert-Buffet N, Fort
J, Pianos A, Eychenne B, Cambourg A, Schumacher M, Berkane N,
Lefevre G, et al: Steroid profiling in preeclamptic women: Evidence
for aromatase deficiency. Am J Obstet Gynecol. 203:477.e1–e9. 2010.
View Article : Google Scholar
|
|
11
|
Lowe DT: Nitric oxide dysfunction in the
pathophysiology of preeclampsia. Nitric Oxide. 4:441–458. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanasaki K, Palmsten K, Sugimoto H, Ahmad
S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, et
al: Deficiency in catechol-O-methyltransferase and
2-methoxyoestradiol is associated with pre-eclampsia. Nature.
453:1117–1121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki H, Ohkuchi A, Shirasuna K,
Takahashi H, Usui R and Matsubara S: Animal models of preeclampsia:
Insight into possible biomarker candidates for predicting
preeclampsia. Med J Obstet Gynecol. 2:10312014.
|
|
14
|
Gilbert JS, Babcock SA and Granger JP:
Hypertension produced by reduced uterine perfusion in pregnant rats
is associated with increased soluble fms-like tyrosine kinase-1
expression. Hypertension. 50:1142–1147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumasawa K: Animal models in preeclampsia.
Preeclampsia. Springer Nature Singapore; pp. 141–155. 2018,
View Article : Google Scholar
|
|
16
|
Zeisler H, Jirecek S, Hohlagschwandtner M,
Knofler M, Tempfer C and Livingston JC: Concentrations of estrogens
in patients with preeclampsia. Wien Klin Wochenschr. 114:458–461.
2002.PubMed/NCBI
|
|
17
|
Sun MN and Zi Y: Effects of
preeclampsia-like symptoms at early gestational stage on
feto-placental outcomes in a mouse model. Chin Med J (Engl).
123:707–712. 2010.PubMed/NCBI
|
|
18
|
Yang H, Ahn C and Jeung EB: Differential
expression of calcium transport genes caused by COMT inhibition in
the duodenum, kidney and placenta of pregnant mice. Mol Cell
Endocrinol. 401:45–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nathan HL, Duhig K, Hezelgrave NL,
Chappell LC and Shennan AH: Blood pressure measurement in
pregnancy. Obstetr Gynaecol. 17:91–98. 2015.
|
|
20
|
Spradley FT, Tan AY, Joo WS, Daniels G,
Kussie P, Karumanchi SA and Granger JP: Placental growth factor
administration abolishes placental ischemia-induced hypertension.
Hypertension. 67:740–747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berg A, Fasmer KE, Mauland KK, Ytre-Hauge
S, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, et
al: Tissue and imaging biomarkers for hypoxia predict poor outcome
in endometrial cancer. Oncotarget. 7:69844–69856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yasujima M, Abe K, Kohzuki M, Tanno M,
Kasai Y, Sato M, Omata K, Kudo K, Takeuchi K, Hiwatari M, et al:
Effect of atrial natriuretic factor on angiotensin II-induced
hypertension in rats. Hypertension. 8:748–753. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Costa RA, Hoshida MS, Alves EA, Zugaib M
and Francisco RP: Preeclampsia and superimposed preeclampsia: The
same disease? The role of angiogenic biomarkers. Hypertens
Pregnancy. 35:139–149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tal R: The role of hypoxia and
hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol
Reprod. 87:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaspar JM and Velloso LA: Hypoxia
inducible factor as a central regulator of metabolism-implications
for the development of obesity. Front Neurosci. 12:8132018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Olson N and Van Der Vliet A: Interactions
between nitric oxide and hypoxia-inducible factor signaling
pathways in inflammatory disease. Nitric Oxide. 25:125–137. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arendt KW and Garovic VD: Association of
deficiencies of catechol-O-methyltransferase and 2-methoxyestradiol
with preeclampsia. Expert Rev Obstetr Gynecol. 4:379–381. 2009.
View Article : Google Scholar
|
|
28
|
Zheng L, Huang J, Su Y, Wang F, Kong H and
Xin H: Vitexin ameliorates preeclampsia phenotypes by inhibiting
TFPI-2 and HIF-1α/VEGF in al-NAME induced rat model. Drug Dev Res.
80:1120–1127. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kulkarni K: HIF-1 alpha: A master
regulator of trophoblast differentiation and placental development.
Browse Theses Dissertations. 943:2009, https://corescholar.libraries.wright.edu/etd_all/943September
3–2020
|
|
30
|
Saravani M, Rokni M, Mehrbani M,
Amirkhosravi A, Faramarz S, Fatemi I, Esmaeili Tarzi M and
Nematollahi MH: The evaluation of VEGF and HIF-1α gene
polymorphisms and multiple sclerosis susceptibility. J Gene Med.
21:e31322019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mizukami Y, Li J, Zhang X, Zimmer MA,
Iliopoulos O and Chung DC: Hypoxia-inducible factor-1-independent
regulation of vascular endothelial growth factor by hypoxia in
colon cancer. Cancer Res. 64:1765–1772. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pant V, Yadav BK and Sharma J: A cross
sectional study to assess the sFlt-1:PlGF ratio in pregnant women
with and without preeclampsia. BMC Pregnancy Childbirth.
19:2662019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schrier RW: Renal and Electrolyte
Disorders. Lippincott Williams & Wilkins; Philadelphia, PA:
2010
|
|
34
|
Banek CT, Bauer AJ, Gingery A and Gilbert
JS: Timing of ischemic insult alters fetal growth trajectory,
maternal angiogenic balance, and markers of renal oxidative stress
in the pregnant rat. Am J Physiol Regul Integr Comp Physiol.
303:R658–R664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salari S, Eskandari M, Nanbakhsh F and
Dabiri A: Evaluation of androgen and progesterone levels in women
with preeclampsia. Iranian J Med Sci. 30:186–189. 2015.
|
|
36
|
Kaludjerovic J and Ward WE: The interplay
between estrogen and fetal adrenal cortex. J Nutr Metab.
2012:8379012012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Furukawa S, Tsuji N and Sugiyama A:
Morphology and physiology of rat placenta for toxicological
evaluation. J Toxicol Pathol. 32:1–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Buster JE: Gestational changes in steroid
hormone biosynthesis, secretion, metabolism, and action. Clin
Perinatol. 10:527–552. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu XQ, Song R and Zhang L: Effect of
oxidative stress on the estrogen-NOS-NO-KCa channel pathway in
uteroplacental dysfunction: Its implication in pregnancy
complications. Oxid Med Cell Longev. 2019:91942692019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vonnahme KA, Wilson ME and Ford SP:
Relationship between placental vascular endothelial growth factor
expression and placental/endometrial vascularity in the pig. Biol
Reprod. 64:1821–1825. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maliqueo M, Echiburú B and Crisosto N: Sex
steroids modulate uterine-placental vasculature: Implications for
obstetrics and neonatal outcomes. Front Physiol. 7:1522016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kanasaki K and Kanasaki M: Angiogenic
defects in preeclampsia: What is known, and how are such defects
relevant to preeclampsia pathogenesis? Hypertension Res Pregnancy.
1:57–65. 2013. View Article : Google Scholar
|
|
43
|
Liu D, Iruthayanathan M, Hosman LL, Wang
Y, Yang L, Wang Y and Dillon JS: Dehydroepiandrosterone stimulates
endothelial proliferation and angiogenesis through extracellular
signal-regulated kinase 1/2-mediated mechanisms. Endocrinology.
149:889–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Barnabas O, Wang H and Gao XM: Role of
estrogen in angiogenesis in cardiovascular diseases. J Geriatr
Cardiol. 10:377–382. 2013.PubMed/NCBI
|
